Protagenic Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
Protagenic Therapeutics, Inc. Earnings Date And Information
Protagenic Therapeutics, Inc. last posted its earnings results on Tuesday, November 16th, 2021. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.12. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Protagenic Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.15 diluted earnings per share) and currently has a price-to-earnings ratio of -0.57. Protagenic Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Protagenic Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.36 | $0 | $0 | ||
| 05/15/2024 | Q1 2024 | -$0.39 | $0 | |||
| 05/14/2024 | Q4 2023 | -$0.38 | $3,200 | |||
| 11/14/2023 | Q3 2023 | -$0.32 | $0 | |||
| 08/14/2023 | Q2 2023 | -$0.28 | $0 | |||
| 05/15/2023 | Q1 2023 | -$0.17 | $0 | |||
| 04/17/2023 | Q4 2022 | -$0.14 | $0 | |||
| 11/14/2022 | Q3 2022 | -$0.21 | $0 | |||
| 08/11/2022 | Q2 2022 | -$0.15 | $0 | |||
| 05/13/2022 | Q1 2022 | -$0.31 | $0 | |||
| 04/07/2022 | Q4 2021 | -$0.22 | $-480,510 | |||
| 11/15/2021 | Q3 2021 | -$0.21 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.43 | $0 | |||
| 05/17/2021 | Q1 2021 | -$0.46 | $0 | |||
| 03/25/2021 | Q4 2020 | -$0.20 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.41 | $0 | |||
| 08/14/2020 | Q2 2020 | -$0.22 | $0 | |||
| 06/18/2020 | Q1 2020 | -$0.19 | $0 | |||
| 04/28/2020 | Q4 2019 | -$0.29 | $0 | |||
| 11/14/2019 | Q3 2019 | -$0.05 | $0 |
Protagenic Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Protagenic Therapeutics, Inc.'s earnings date?
Protagenic Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to Protagenic Therapeutics, Inc.'s earnings conference call?
The conference call for Protagenic Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Protagenic Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Protagenic Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Protagenic Therapeutics, Inc. generate each year?
Protagenic Therapeutics, Inc. (:PTIX) has a recorded net income of $0. Protagenic Therapeutics, Inc. has generated $-1.15 earnings per share over the last four quarters.
-
What is Protagenic Therapeutics, Inc.'s price-to-earnings ratio?
Protagenic Therapeutics, Inc. (:PTIX) has a price-to-earnings ratio of -0.57 and price/earnings-to-growth ratio is 0.1.
